Chhetri Sunit, Manandhar Srista, Neupane Durga, Subedi Sushil Sharma, Chhetri Sunny, Acharya Astha, Chaudhary Sushant, Khatiwada Pradeep, Shrestha Suraj
BP Koirala Institute of Health Sciences, Ghopa Camp, Dharan-18, Sunsari, Province 1, 56700, Nepal.
Department of Surgery, BP Koirala Institute of Health Sciences, Ghopa Camp, Dharan-18, Sunsari, Province 1, Nepal.
Ann Med Surg (Lond). 2022 Jul 31;80:104232. doi: 10.1016/j.amsu.2022.104232. eCollection 2022 Aug.
Erdheim-Chester Disease (ECD) is a rare non-Langerhans cell histiocytosis with a propensity to involve multiple organs.
We report a case of a patient in mid-60s with occipital headache and ataxia. Following the radiological and immunohistochemical investigations and genomic studies, a diagnosis of ECD was made with two intracerebral lesions. Brain lesions were resected and the patient was discharged with the medication Vemurafenib. After 3 years of diagnosis and 13 years of initial presentation, patient passed away.
ECD frequently presents with Diabetes Insipidus as initial presentation, long bone osteosclerosis as the most common presentation, and has multi-system predisposition. ECD can be differentiated from Langerhans Cell Histiocytosis (LCH) with immunohistochemistry images of the biopsy specimens. Further, with genomic analysis of ECD, the neoplastic nature has been highlighted and targeted therapies like Vemurafenib and Cobimetinib are shown to be effective.
Good clinical judgement and supporting investigations can aid in diagnosing rare entities like ECD even in resource-limited settings.
厄尔德海姆-切斯特病(ECD)是一种罕见的非朗格汉斯细胞组织细胞增多症,易累及多个器官。
我们报告一例60多岁的患者,有枕部头痛和共济失调症状。经过放射学、免疫组织化学检查及基因组研究,诊断为ECD伴两处脑内病变。脑病变被切除,患者出院时服用维莫非尼。确诊3年后,即首次出现症状13年后,患者去世。
ECD常以尿崩症为首发表现,长骨骨硬化为最常见表现,且有多系统易感性。通过活检标本的免疫组织化学图像可将ECD与朗格汉斯细胞组织细胞增多症(LCH)区分开来。此外,通过对ECD的基因组分析,其肿瘤性质得以凸显,维莫非尼和考比替尼等靶向治疗显示有效。
良好的临床判断和辅助检查有助于在资源有限的情况下诊断像ECD这样的罕见疾病。